1. The metabolism of L-tryptophan by isolated liver cells prepared from control, adrenalectomized, glucocorticoid-treated, acute-diabetic, chronic-diabetic and insulin-treated chronic-diabetic rats was studied. 2. Liver cells from adrenalectomized rats metabolized tryptophan at rates comparable with the minimum diurnal rates of controls, but different from rates determined for cells from control rats 4h later. 3. Administration of dexamethasone phosphate increased the activity of tryptophan 2,3-dioxygenase (EC 1.13.11.11) 7-8-fold, and the flux through the kynurenine pathway 3-4-fold, in cells from both control and adrenalectomized rats. Increases in flux through kynureninase (EC 3.7.1.3) and to acetyl-CoA can be explained in terms of increased substrate supply from tryptophan 2,3-dioxygenase. 4. The metabolism of tryptophan was increased 3-fold in liver cells isolated from acutely (3 days) diabetic rats, with a 7-8-fold increase in the maximal activity of tryptophan 2,3-dioxygenase. The oxidation of tryptophan to CO2 and metabolites of the glutarate pathway increased 4-5-fold, consistent with an increase in picolinate carboxylase (EC 4.1.1.45) activity. 5. Liver cells isolated from chronic (10 days) diabetic rats metabolized tryptophan at rates comparable with those of cells from acutely diabetic rats, but with a 50% decrease in the activity of tryptophan 2,3-dioxygenase. The proportion of flux from tryptophan 2,3-dioxygenase to acetyl-CoA, however, was increased by 50%; this was indicative of further increases in the activity of picolinate carboxylase. 6. Administration of insulin partially reversed the effects of chronic diabetes on the activity of tryptophan 2,3-dioxygenase and flux through the kynurenine pathway, but had no effect on the increased activity of picolinate carboxylase. 7. The role of tryptophan 2,3-dioxygenase in regulating the blood tryptophan concentration is discussed with reference to its sensitivity to the above conditions.
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In mammals more than 90% of the total tryptophan is degraded in the liver through the kynureninase pathway (Young et al., 1978) . The importance of the regulation of this process is emphasized by the relationship between the plasma tryptophan concentration and the synthesis of 5-hydroxytryptamine in the brain (Curzon, 1979 (Knox & Mehler, 1951; Voigt & Sekeris, 1980) and by tryptophan itself (Knox, 1951 (Knox, , 1966 , although possibly by different mechanisms (Civen & Knox, 1959) . In common with that of tyrosine aminotransferase (Ltyrosine: 2-oxoglutarate aminotransferase, EC 2.6.1.5), tryptophan 2,3-dioxygenase activity in rat liver exhibits a diurnal rhythm which correlates closely with the concentration of corticosterone in the blood (Wurtman, 1974) . Although the sensitivity of total dioxygenase activity to steroid has been well documented (see, e.g., Schimke & Doyle, 1970) , there are no reports relating this phenomenon to flux through the pathway under otherVol. 229 wise physiological conditions. It has been suggested, on the basis of measurements of maximal activities in vitro, that kynureninase (L-kynurenine hydrolase, EC 3.7.1.3) may become a significant factor in overall regulation of the pathway when the dioxygenase concentration is increased by steroid administration (Knox, 1953; Magboul & Bender, 1983) . It is far from clear, however, that such measurements in vitro can be interpreted directly in the physiological context.
The activities of both tryptophan 2,3-dioxygenase and picolinate carboxylase (aminocarboxymuconate-semialdehyde carboxylase, EC 4.1.1.45) are increased in the livers of chronically diabetic rats (Mehleretal., 1958a; Ikedaetal., 1965) . Picolinate carboxylase controls the relative fluxes oftryptophan carbon to nicotinamide coenzymes and to further oxidation (Mehler et al., 1964) , and it has been suggested that the increased activity of this enzyme serves to decrease synthesis of nicotinamide coenzymes in diabetes (Mehler et al., 1958a; McDaniel et al., 1973) . This increased activity is reversed by insulin, but only after long-term treatment (Sanada et al., 1980) . The effects of diabetes on tryptophan metabolism in vivo are known from measurements of metabolites in urine (Kotake & Tani, 1953; Mehler et al., 1958a) , but these data include contributions from other tissues (Rose, 1972) , so that the specific effects on flux in the liver are not known.
In the present paper we report studies with liver cells exposed to glucocorticoid and from animals rendered both acutely and chronically diabetic with streptozotocin. Correlations are made between flux data in cells and enzyme activities assayed in cell extracts.
Materials and methods

Animals
Male Sprague-Dawley rats (180-220g) were used throughout, and were given a standard laboratory diet (CRM diet; Labsure, Poole, Dorset, U.K.) ad libitum. Bilateral adrenalectomy was performed as described by Smith & Pogson (1977) ; adrenalectomized rats were given 1% (w/v) NaCI instead of drinking water. Half of the adrenalectomized rats were given dexamethasone phosphate, subcutaneously under diethyl ether anaesthesia, at 10:00 daily (2mg/kg body wt., in pyrogen-free 0.9% NaCl). Tryptophan 2,3-dioxygenase activity was unaffected by subcutaneous administration of 0.9% NaCl under diethyl ether anaesthesia.
Control rats were given dexamethasone phosphate, intraperitoneally, at 07:30h (3mg/animal, in 0.9% NaCl) 5h before liver-cell preparation.
Diabetes was induced by intravenous injection into the caudal vein of streptozotocin (80mg/kg body wt., in 0.9% pyrogen-free NaCI). Diabetes was confirmed by the appearance of glucose in the urine (Clinistix; Ames Co., Slough, Berks., U.K.). Insulin was administered intraperitoneally twice daily (3 units/animal; Neusulin, Wellcome, Beckenham, Kent, U.K.). Isolated liver cells were prepared from normal fed rats (controls), from rats 5 days after adrenalectomy and from rats 3 days or 10 days after streptozotocin injection.
Chemicals and purification of labelled compounds All radiochemicals were from Amersham International, Amersham, Bucks., U.K., except for L-[ring-2-'4C]tryptophan, which was from CEA, Gif-sur-Yvette, France, through Fluorochem, Glossop, Derbyshire, U.K. The sources of other reagents were as given previously (Salter et al., 1984) .
Radiolabelled L-tryptophan was purified by affinity chromatography (Stewart & Doherty, 1973) as described in detail by Smith (1977) .
Preparation and incubation of cells
The procedures were as described previously , with the following amendments. (1) Liver-cell preparation started at 12:30h each day, unless stated. (w/v) bovine serum albumin (defatted as described by Chen, 1967) and supplemented with 5mM-Dglucose, 5 mM-L-glutamine, 4.5 mM-L-lactate and 0.5mM-pyruvate. These substrates were added to maintain glycogen stores. The final cell concentration was 2.5-3.5mg dry wt./ml, final volume 2ml. (5) Cells were preincubated for 25 min before addition of tryptophan, and incubated for a further 30min or 90min before metabolism was terminated with 200,p of 20% (v/v) HCl04.
Flux through the tryptophan catabolic pathway was assessed as described in detail by .
Assays
Determinations of the maximal activity of tryptophan 2,3-dioxygenase, in cell extracts, were as described by Metzler et al. (1982) . Extracts were prepared as previously described (Salter et al., 1984) . Cell viability was asessed on each occasion by measurement of ATP content (Stanley & Williams, 1969) . All results were obtained with cells with ATP contents more than 8nmol/mg dry wt. DNA was measured as described by Burton (1956) .
Results and discussion EjIect of glucocorticoid Table 1 shows the effects of variations in glucocorticoid status on tryptophan metabolism in liver cells. Adrenalectomy had no significant effect on either the intracellular degradation of tryptophan or the total activity of tryptophan 2,3-dioxygenase. This lack of effect on flux confirms previous results (Smith & Pogson, 1981 (Nakamura et al., 1980) . However, if glucocorticoids are permissive for both the long-and short-term actions of glucagon (Krone et al., 1976; Postle & Bloxham, 1982) , one would not expect to see any change in activity in adrenalectomized rats. The lack of effect of hypoinsulinaemia (Van Lan et al., 1974) on the activity of the dioxygenase (Table 1) suggests that insulin may only attenuate the activity after its increase by glucagon.
Replacement of glucocorticoid with low doses of dexamethasone phosphate resulted in a 7-8-fold increase in the total activity of tryptophan 2,3-dioxygenase and a 3-fold increase in the flux through the enzyme in cell incubations. Parallel increases in flux through the rest of the pathway were seen, suggesting that the dioxygenase plays a significant role in the regulation of the overall process. A similar increase in the activity of the dioxygenase and flux through the kynurenine pathway was seen when a larger dose of dexamethasone phosphate was given intraperitoneally to control rats 5h before the experiment. Thus the metabolism of tryptophan in cells from control and adrenalectomized rats shows a similar response to glucocorticoid. Vol. 229
When the control experiment was repeated 4h later (i.e. at 16: 30 h), the metabolism of tryptophan had increased significantly from values determined at the earlier time. The concentration of circulating blood glucocorticoid should, at this time, be increased from its diurnal minimum (Wurtman & Axelrod, 1967) . Thus increases in circulating steroid are associated with increases in both enzyme protein and flux through the pathway, although these increases are not necessarily parallel.
E.fect of diabetes and insulin replacement
Acute streptozotocin-induced diabetes increased the metabolism of tryptophan by isolated liver cells 3-4-fold, with an 8-fold increase in tryptophan 2,3-dioxygenase activity (Table 2 ). This increased synthesis of tryptophan 2,3-dioxygenase may be associated with the large rise in the glucagon/insulin ratio; Nakamura et al. (1980) have shown that glucagon is a potent inducer of the synthesis of tryptophan 2,3-dioxygenase in cultured rat liver cells. Steroid is unlikely to be involved in these effects; there are negligible differences in plasma corticosterone concentrations between control and acutely diabetic rats (R. G. Knowles & C. I. Pogson, unpublished work) . The ratio of the flux to acetyl-CoA to that through tryptophan 2,3-dioxygenase was increased by 50%. This suggests that the activity of picolinate carboxylase was increased, thereby diverting the tryptophan-derived carbon flux away from nicotinamide synthesis. The flux through kynureninase increased solely as a response to the increased substrate supply from tryptophan 2,3-dioxygenase.
Chronic (10 days) diabetes again was associated with an increase in the metabolism of tryptophan by isolated rat liver cells. The flux through tryptophan 2,3-dioxygenase was decreased only slightly from the values found for cells from acutely diabetic rats; the total activity of tryptophan 2,3-dioxygenase, however, was decreased by 50%.
The proportion of tryptophan metabolized to acetyl-CoA was greater in cells from chronically than from acutely diabetic rats. This is indicative of a further increase in the activity of picolinate carboxylase. This increased activity of picolinate carboxylase did not, however, decrease the absolute flux to the nicotinamide coenzymes (cf. Smith & Pogson, 1981) , because the overall flux through the pathway is increased. It is worth noting, nevertheless, that the basal activity of picolinate carboxylase in man (Ikeda et al., 1965) is twice that of the rat, so that defective synthesis of NAD(P) is a possibility in human diabetes.
Daily injection of insulin resulted in a significant decrease in the activity of tryptophan 2,3-dioxy- The activity of picolinate carboxylase, however, was not affected by the administration of insulin, at least as demonstrated by an uncharged ratio of flux through the dioxygenase to flux to acetyl-CoA through the lower part of the pathway (again in comparison with cells from diabetic animals). Mehler et al. (1958b) have shown that the activity of picolinate carboxylase, which is elevated in diabetes, returns to control values only after 3 weeks of insulin treatment; this may be indicative of a long half-life for picolinate carboxylase in rat liver.
General discussion
The rate-limiting enzyme for 5-hydroxytryptamine synthesis in the brain, tryptophan hydroxylase (L-tryptophan, tetrahydropteridine: oxygen oxidoreductase, EC 1.14.16.4) (Jequir et al., 1967) is thought to be not fully saturated with substrate in vivo (Knowles & Pogson, 1984) . Thus changes in the tryptophan concentration in the blood may be significant as a determinant of the concentration of 5-hydroxytryptamine in the brain. It is of interest, therefore, that the total concentration of plasma tryptophan is decreased in chronic diabetes in the rat (Crandall & Fernstrom, 1983) and in ketoacidotic diabetes in man (Curzon et al., 1982) . Although there is likely to be an increased input of tryptophan in diabetes because of increased muscle proteolysis, there will be a net loss to the body as a result of the increased metabolism of tryptophan by the liver. This increase in metabolism arises from the increase in activity of tryptophan 2,3-dioxygenase and also from an increase in free, and thus available, tryptophan (Fernando et al., 1976; Curzon et al., 1982) . The relative concentration of free tryptophan (as a proportion of the total) is elevated in diabetes, because of the displacement -of bound amino acid by free fatty acid (Knott & Curzon, 1972; . The concentration oftotal plasma tryptophan, however, is unchanged in acute diabetes (Fernando et al., 1976) , which may reflect a higher rate of muscle proteolysis in the acutely diabetic rat, compared with the chronically diabetic rat (as the rate of disposal is approximately constant; Table 2 ). Crandall & Fernstrom (1983) have shown that administration of insulin to chronically diabetic rats returns the concentrations of tryptophan in blood and brain to control values. This is consistent with the observed effects of insulin on flux through tryptophan 2,3-dioxygenase (Table 2) and with the hypothesis that the regulation of tryptophan 2,3-dioxygenase may be an important factor in the maintenance of blood tryptophan, and, as a result, of the concentration of 5-hydroxytryptamine in the brain, although a direct relationship between plasma tryptophan and 5-hydroxytryptamine synthesis does not always occur (Trulson & MacKenzie, 1980) . Work in our laboratory has shown that the activity of the major regulatory enzyme of tyrosine catabolism in the liver, tyrosine aminotransferase, is also increased in chronic diabetes (and antagonized by insulin administration) (J. C. Stanley, M. J. Fisher & C. I. Pogson, unpublished work). Interestingly, Crandall & Fernstrom (1983) observed changes in plasma tyrosine which paralleled those of tryptophan in the diabetic state, although Curzon et al. (1982) saw no change in human ketoacidotic diabetes. The role of both amino acids as precursors of neurotransmitters suggests that significant alterations in central nervous activity may be associated with prolonged diabetes.
It is clear that the basal capacity of the liver to metabolize tryptophan is unaffected by the absence of glucocorticoid. However, larger loads of trypotophan are handled much less effectively by adrenalectomized rats (Smith & Pogson, 1981) , presumably because of the inability of these rats to produce glucocorticoid and thus increase tryptophan 2,3-dioxygenase activity. Smith & Pogson (1977) have shown that tryptophan is much more toxic to adrenalectomized rats than to normal rats. The activity of tryptophan 2,3-dioxygenase is clearly very sensitive to the diurnal increases in blood glucocorticoid. The consequent increased capacity of the liver to degrade tryptophan is required to prevent excessive increases in the amino acid in the blood, especially at times of increased input, such as feeding or increased muscle degradation.
The relationship between the total activity of tryptophan 2,3-dioxygenase and its flux divided by the total activity for control and experimental rats is shown in Fig. 1 . It is clear from Fig. 1 that the flux in cells does not increase linearly with the activity in cell extracts (if this were so, the flux/activity ratio would remain constant with increasing activity) and that at high enzyme activity other factors become significant for the control of tryptophan oxidation. We have shown that the transport of tryptophan into liver cells is relatively slow and may become limiting with increased dioxygenase activities (M. Salter & C. I. Pogson, unpublished work).
We gratefully acknowledge financial support from the Medical Research Council.
